Taichu Biotechnology
Shanghai
About Taichu Biotechnology
Taichu Biotechnology offers customized CRO+CDMO technical services for single and combined business sectors for the development and manufacturing of various novel pharmaceuticals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $44.2M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2023)
- Website: taichubio.com
Industries & Categories
Medical, Pharmaceutical, Product Research
Canonical: https://fsome.com/organization/taichu-biotechnology-153019 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.